Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1170.69 | 578 / 578 | 100% | 17.99 | 1155 / 1155 |
prostate | 100% | 947.65 | 245 / 245 | 100% | 18.94 | 502 / 502 |
stomach | 100% | 784.49 | 359 / 359 | 100% | 16.48 | 286 / 286 |
esophagus | 100% | 1195.91 | 1443 / 1445 | 100% | 12.56 | 183 / 183 |
thymus | 100% | 929.87 | 653 / 653 | 100% | 11.98 | 604 / 605 |
bladder | 100% | 818.00 | 21 / 21 | 100% | 19.58 | 503 / 504 |
skin | 100% | 1121.81 | 1809 / 1809 | 100% | 12.73 | 471 / 472 |
uterus | 100% | 824.55 | 170 / 170 | 100% | 16.39 | 458 / 459 |
kidney | 100% | 1010.81 | 89 / 89 | 100% | 11.91 | 899 / 901 |
breast | 100% | 991.94 | 459 / 459 | 100% | 18.47 | 1115 / 1118 |
intestine | 100% | 902.34 | 966 / 966 | 100% | 19.92 | 525 / 527 |
liver | 100% | 750.97 | 225 / 226 | 100% | 12.97 | 406 / 406 |
ovary | 99% | 491.01 | 178 / 180 | 100% | 18.59 | 430 / 430 |
pancreas | 98% | 580.74 | 323 / 328 | 99% | 16.78 | 177 / 178 |
adrenal gland | 100% | 1111.18 | 258 / 258 | 98% | 10.39 | 225 / 230 |
brain | 87% | 290.55 | 2304 / 2642 | 94% | 7.01 | 660 / 705 |
adipose | 100% | 995.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 11.68 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 14.95 | 29 / 29 |
spleen | 100% | 973.84 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 16.43 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.83 | 1 / 1 |
blood vessel | 100% | 872.70 | 1331 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 1094.89 | 920 / 929 | 0% | 0 | 0 / 0 |
heart | 96% | 508.95 | 830 / 861 | 0% | 0 | 0 / 0 |
muscle | 82% | 339.60 | 657 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_0006672 | Biological process | ceramide metabolic process |
GO_0090156 | Biological process | intracellular sphingolipid homeostasis |
GO_1900060 | Biological process | negative regulation of ceramide biosynthetic process |
GO_0017059 | Cellular component | serine palmitoyltransferase complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | ORMDL2 |
Protein name | ORM1-like protein 2 (Adoplin-2) ORMDL sphingolipid biosynthesis regulator 2 |
Synonyms | MSTP095 HSPC160 |
Description | FUNCTION: Plays an essential role in the homeostatic regulation of sphingolipid de novo biosynthesis by modulating the activity of the serine palmitoyltransferase (SPT) in response to ceramide levels . When complexed to SPT, the binding of ceramides to its N-terminus stabilizes a conformation that block SPT substrate entry, hence preventing SPT catalytic activity. Through this mechanism, maintains ceramide levels at sufficient concentrations for the production of complex sphingolipids, but which prevents the accumulation of ceramides to levels that trigger apoptosis (By similarity). . |
Accessions | Q53FV1 F8VXD5 F8VWV8 ENST00000550836.1 ENST00000548974.1 ENST00000243045.10 ENST00000552672.5 |